Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Status in Jerusalem Males
NCT01025128Phase 4Completed
- Sponsor
- Clalit Health Services
- Start
- Jan 2010
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of calcifediol in Vitamin D deficiency (VDD), secondary hyperparathyroidism (SHPT) and osteomalacia, sponsored by Clalit Health Services. Started Jan 2010; status: completed.
02
Drugs
calcifediol
03
Conditions
Vitamin D deficiency (VDD)secondary hyperparathyroidism (SHPT)osteomalacia
Beyond the preview
Go deeper on NCT01025128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025128.